MOXI trial—is it time to stop routinely recommending antioxidant therapy to infertile men?

Reflections

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Published
Like Comment
Related Content

Volume 113, Issue 3, Page 542

Author:

Martin Kathrins, M.D.

Abstract:

Reflections on "The effect of antioxidants on male factor infertility: the MOXI randomized clinical trial" by Steiner et al.


Read the full text here.

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.